STATE-OF-THE-ART PAPER
Alcohol and Cardiovascular HealthThe Razor-Sharp Double-Edged Sword
James H. O’Keefe, MD, FACC*,*,
Kevin A. Bybee, MD* and
Carl J. Lavie, MD, FACC
* Mid America Heart Institute, University of Missouri, Kansas City, Missouri
Ochsner Medical Center, New Orleans, Louisiana.
Manuscript received February 14, 2007;
revised manuscript received April 19, 2007,
accepted April 30, 2007.
* Reprint requests and correspondence: Dr. James O’Keefe, 4330 Wornall Road, Suite 2000, Kansas City, Missouri 64111. (Email: jhokeefe{at}cc-pc.com).
An extensive body of data shows concordant J-shaped associations between alcohol intake and a variety of adverse health outcomes, including coronary heart disease, diabetes, hypertension, congestive heart failure, stroke, dementia, Raynaud’s phenomenon, and all-cause mortality. Light to moderate alcohol consumption (up to 1 drink daily for women and 1 or 2 drinks daily for men) is associated with cardioprotective benefits, whereas increasingly excessive consumption results in proportional worsening of outcomes. Alcohol consumption confers cardiovascular protection predominately through improvements in insulin sensitivity and high-density lipoprotein cholesterol. The ethanol itself, rather than specific components of various alcoholic beverages, appears to be the major factor in conferring health benefits. Low-dose daily alcohol is associated with better health than less frequent consumption. Binge drinking, even among otherwise light drinkers, increases cardiovascular events and mortality. Alcohol should not be universally prescribed for health enhancement to nondrinking individuals owing to the lack of randomized outcome data and the potential for problem drinking.
|
Abbreviations and Acronyms
| | CHD = coronary heart disease | | CV = cardiovascular | | HDL = high-density lipoprotein | | MI = myocardial infarction |
|
This article has been cited by other articles:
|
|
|
|
 
R. Balakrishnan, S. Allender, P. Scarborough, P. Webster, and M. Rayner
The burden of alcohol-related ill health in the United Kingdom
J. Public Health Med.,
June 3, 2009;
(2009)
fdp051v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.H. Song
Alcohol--it's more than the liver
QJM,
March 1, 2009;
102(3):
221 - 222.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-C. Fruchart, F. M Sacks, M. P Hermans, G. Assmann, W V. Brown, R. Ceska, M J. Chapman, P. M Dodson, P. Fioretto, H. N Ginsberg, et al.
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
Diabetes and Vascular Disease Research,
November 1, 2008;
5(4):
319 - 335.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Z. Fan, M. Russell, T. Naimi, Y. Li, Y. Liao, R. Jiles, and A. H. Mokdad
Patterns of Alcohol Consumption and the Metabolic Syndrome
J. Clin. Endocrinol. Metab.,
October 1, 2008;
93(10):
3833 - 3838.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Spaak, A. C. Merlocco, G. J. Soleas, G. Tomlinson, B. L. Morris, P. Picton, C. F. Notarius, C. T. Chan, and J. S. Floras
Dose-related effects of red wine and alcohol on hemodynamics, sympathetic nerve activity, and arterial diameter
Am J Physiol Heart Circ Physiol,
February 1, 2008;
294(2):
H605 - H612.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. O'Keefe, N. M. Gheewala, and J. O. O'Keefe
Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health
J. Am. Coll. Cardiol.,
January 22, 2008;
51(3):
249 - 255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Lavie and R. V. Milani
Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era.
J. Am. Coll. Cardiol.,
January 1, 2008;
51(1):
56 - 58.
[Full Text]
[PDF]
|
|
|
|
